Table. Baseline characteristics of subjects.
| Characteristics | Healthy (n = 28) | AR (n = 35) | Non-responder AIT (n = 11) | Responder AIT (n = 26) | |
|---|---|---|---|---|---|
| Sex (female) | 16 (57.1) | 20 (57.1) | 5 (45.4) | 14 (53.8) | |
| Age (yr) | 42.8 ± 7.2 | 36.2 ± 9.5 | 35.2 ± 8.9 | 37.5 ± 5.9 | |
| Duration of disease (yr) | 2.1 ± 1.4 | 5.2 ± 3.4 | 4.9 ± 2.5 | ||
| Co-morbid disease | |||||
| Asthma | 3 (8.6) | 2 (18.1) | 3 (11.5) | ||
| Atopic dermatitis | 1 (2.9) | 2 (18.1) | 2 (7.7) | ||
| Allergic conjunctivitis | 8 (22.9) | 4 (36.4) | 5 (19.2) | ||
| Total IgE (kU/L) | 67.8 ± 27.3 | 265.3 ± 138.4 | 312.5 ± 157.1 | 294.4 ± 164.7 | |
| VAS (mm) | 0 ± 0 | 78.8 ± 14.6 | 72.3 ± 9.3 | 4.0 ± 4.2 | |
| Medication score | 0 ± 0 | 3.8 ± 1.1 | 4.0 ± 0.8 | 0.5 ± 0.5 | |
Values are presented as number of patients (%) or mean ± SD.
AR, allergic rhinitis; AIT, allergen immunotherapy; IgE, immunoglobulin E; VAS, visual analog scale; SD, standard deviation